MP says Palantir is ‘albatross hanging around NHS’s neck’ as government urged to end contract

Independent Membership

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today.

Join today

Already a member? Log in

Ministers have indicated that US tech firm Palantir could lose its NHS contract following the announcement of a fresh procurement process for the federated data platform (FDP).

A consortium headed by Palantir was awarded a £330 million agreement in 2023 to build the platform, which aims to help health service organisations connect their data.

Its involvement in the FDP raised concerns over how patient data will be used, with Prime Minister Andy Burnham coming under pressure to sever links with the technology giant.

One backbencher called on ministers to "get rid of the albatross of Palantir which is hanging around the NHS’s neck", as others argued the contract should end sooner.

The technology enterprise was co-founded by billionaire Peter Thiel, an early supporter of US President Donald Trump.

It holds contracts with the Israel Defence Forces (IDF) alongside the US’s Immigration and Customs Enforcement (Ice).

Health minister James Frith insisted the move was "not about the politics of executives of suppliers, nor is it about the territories or customers that one company or one supplier makes".

While the current contract could run until 2031, initial terms allow the Government to trigger a break clause to end or renegotiate the deal by spring 2027.

Replacement contracts for the FDP are expected to be in place from 2029, following an 18-month procurement process.

In a statement to the Commons, Mr Frith said the Government’s new approach to procurement would “boost competition, demand interoperability and diversify NHS technology within a safe and modern regulatory framework”.

“This will be an open, fair, transparent process with both UK sovereign capability, SMEs in constituencies across the land being encouraged to tender, as well as any international capability invited to tender,” he later added.

Liberal Democrat health spokeswoman Helen Morgan branded the current Palantir contract “dangerous”, criticising the US tech giant for having “an appalling human rights record, run by an ally of Donald Trump”.

She added: “Lack of trust in Palantir has led to doctors and patients voting with their feet, opting out of sharing their data and undermining the fundamental effectiveness of the FDP system.”

Mr Frith said the decision had been taken “based on measures of use by 137 trusts”.

Labour former shadow chancellor John McDonnell accused Palantir of “human rights abuses” and said his constituents in Hayes and Harlington “expect the contract to be ended”.

He said: “If it isn’t the case, and we’re going through this two-year period, and then rebidding will take place, can we ensure that we build into that process that the criteria will include a humanitarian track record? Because on that basis, we can say to Palantir, no need to apply.”

Mr Frith said the terms of procurement will be issued “in the coming weeks” and would “note” Mr McDonnell’s request.

Chairwoman of the science and technology committee Dame Chi Onwurah said she was “extremely disappointed” Palantir continued to be involved in the FDP.

“If a break clause cannot be exercised because of continuity of care, it is not a break clause, it is a lock-in,” the Labour MP for Newcastle upon Tyne Central and West said.

In a statement, Dame Chi added: “The Government needs to act urgently to procure credible domestic alternatives, strengthen the UK’s sovereignty and reduce its dependence on overseas suppliers.

“The Government should not wait two years, it must start reducing this dependency now.”

Ben Coleman, Labour MP for Chelsea and Fulham, also called for the Government to “get rid of the albatross of Palantir which is hanging around the NHS’s neck”.

Shadow health secretary Damian Hinds warned against the procurement process being influenced by politics or “Labour MPs’ tastes or distastes”.

“It should be about delivering the right spec at the right price for optimal patient care,” he added.

Tom Watson, senior vice president, Palantir UK, said: “This is good news for patients and for the NHS. And it is the right decision to press forward with a programme that, in the words of ministers, ‘is significantly exceeding its benefits forecast and has exceeded every target’ since it launched in 2024.

“We are proud of our work to date to help deliver more operations, speed up discharge and reduce the time patients need to wait to find out if they have cancer – support driven from our European base in the UK which is home to more than one in six of our global workforce.

“We will now redouble our efforts over the next two years to continue and accelerate that support.

“As a result of the announcement, we will also deepen our investment in the UK and respond to the challenge set by the Prime Minister to deliver greater social value.

“The FDP is the right vehicle to deliver the change needed in the NHS, and over the next two years Palantir will do everything in its power to drive that change as far as possible, as fast as possible.”

Tom Guha, crisis campaigner at Amnesty International UK, described the decision as “a victory for healthcare workers, patients and campaigners who refused to give up”.

He criticised Palantir’s support of Israel’s military before adding: “This is welcome progress, but the job is not finished.

“The next two years must be about extracting Palantir from our NHS, not allowing it to become more deeply embedded. NHS trusts and integrated care boards should refuse to expand their use of its platform.”

Original source MP says Palantir is ‘albatross hanging around NHS’s neck’ as government urged to end contract

Back to home